FMR LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 143 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,228,517
+4.4%
79,310
+7.4%
0.00%
Q1 2024$1,176,843
+441.7%
73,830
+471.3%
0.00%
Q4 2023$217,259
-40.1%
12,924
-58.4%
0.00%
Q3 2023$362,748
-63.0%
31,031
-57.4%
0.00%
Q2 2023$979,288
+86.4%
72,864
+129.9%
0.00%
Q1 2023$525,430
+81.7%
31,690
+103.9%
0.00%
Q4 2022$289,116
-46.9%
15,544
-63.4%
0.00%
Q3 2022$544,000
+1713.3%
42,449
+906.4%
0.00%
Q2 2022$30,000
+7.1%
4,218
+24.2%
0.00%
Q1 2022$28,000
+100.0%
3,396
+68.2%
0.00%
Q4 2021$14,000
+16.7%
2,019
-16.5%
0.00%
Q3 2021$12,000
+71.4%
2,419
+109.8%
0.00%
Q2 2021$7,000
-12.5%
1,153
-35.9%
0.00%
Q1 2021$8,000
+33.3%
1,8000.0%0.00%
Q4 2020$6,000
+20.0%
1,8000.0%0.00%
Q3 2020$5,000
+25.0%
1,800
+150.7%
0.00%
Q2 2020$4,000
+300.0%
718
+402.1%
0.00%
Q1 2020$1,0000.0%143
-29.6%
0.00%
Q4 2019$1,0000.0%2030.0%0.00%
Q3 2019$1,000
-50.0%
203
-62.8%
0.00%
Q2 2019$2,000
-99.8%
546
-99.8%
0.00%
Q4 2017$1,173,000
+55.2%
300,0000.0%0.00%
Q3 2017$756,000
-8.7%
300,0000.0%0.00%
Q2 2017$828,000300,0000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Broadfin Capital, LLC 7,097,300$27,750,0004.54%
GREAT POINT PARTNERS LLC 3,817,288$14,926,0002.55%
TANAKA CAPITAL MANAGEMENT INC 256,593$1,003,0002.29%
Consonance Capital Management LP 4,473,607$17,492,0001.58%
Avoro Capital Advisors LLC 3,892,343$15,219,0000.99%
KNOTT DAVID M 380,110$1,486,0000.59%
EAM Investors, LLC 790,872$3,092,0000.55%
Ghost Tree Capital, LLC 550,000$2,151,0000.50%
EAM Global Investors LLC 251,647$984,0000.50%
MANGROVE PARTNERS IM, LLC 924,648$3,615,0000.49%
View complete list of CATALYST PHARMACEUTICALS INC shareholders